2012 Q4 Form 10-Q Financial Statement
#000088572512000043 Filed on November 06, 2012
Income Statement
| Concept | 2012 Q4 | 2012 Q3 | 2011 Q3 |
|---|---|---|---|
| Revenue | $1.820B | $1.735B | $1.874B |
| YoY Change | -1.52% | -7.42% | -2.19% |
| Cost Of Revenue | $606.0M | $558.0M | $680.0M |
| YoY Change | -11.79% | -17.94% | 9.15% |
| Gross Profit | $1.214B | $1.177B | $1.194B |
| YoY Change | 4.57% | -1.42% | -7.66% |
| Gross Profit Margin | 66.7% | 67.84% | 63.71% |
| Selling, General & Admin | $644.0M | $589.0M | $629.0M |
| YoY Change | 4.21% | -6.36% | -0.79% |
| % of Gross Profit | 53.05% | 50.04% | 52.68% |
| Research & Development | $238.0M | $220.0M | $229.0M |
| YoY Change | 3.03% | -3.93% | -0.43% |
| % of Gross Profit | 19.6% | 18.69% | 19.18% |
| Depreciation & Amortization | $100.0M | $70.00M | $75.00M |
| YoY Change | 4.17% | -6.67% | 4.17% |
| % of Gross Profit | 8.24% | 5.95% | 6.28% |
| Operating Expenses | $979.0M | $1.771B | $1.020B |
| YoY Change | 4.93% | 73.63% | -2.11% |
| Operating Profit | $235.0M | -$594.0M | $174.0M |
| YoY Change | 3.07% | -441.38% | -30.68% |
| Interest Expense | -$66.00M | $65.00M | $62.00M |
| YoY Change | -5.71% | 4.84% | -31.87% |
| % of Operating Profit | -28.09% | 35.63% | |
| Other Income/Expense, Net | $0.00 | -$69.00M | -$63.00M |
| YoY Change | -100.0% | 9.52% | -28.41% |
| Pretax Income | $51.00M | -$663.0M | $111.0M |
| YoY Change | -49.0% | -697.3% | -31.9% |
| Income Tax | -$10.00M | $1.000M | -$31.00M |
| % Of Pretax Income | -19.61% | -27.93% | |
| Net Earnings | $61.00M | -$664.0M | $142.0M |
| YoY Change | -42.99% | -567.61% | -25.26% |
| Net Earnings / Revenue | 3.35% | -38.27% | 7.58% |
| Basic Earnings Per Share | -$0.48 | $0.09 | |
| Diluted Earnings Per Share | $44.66K | -$0.48 | $0.09 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 1.373B shares | 1.393B shares | 1.514B shares |
| Diluted Shares Outstanding | 1.393B shares | 1.524B shares |
Balance Sheet
| Concept | 2012 Q4 | 2012 Q3 | 2011 Q3 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $207.0M | $352.0M | $276.0M |
| YoY Change | -22.47% | 27.54% | -55.77% |
| Cash & Equivalents | $207.0M | $352.0M | $276.0M |
| Short-Term Investments | |||
| Other Short-Term Assets | $714.0M | $713.0M | $728.0M |
| YoY Change | 8.02% | -2.06% | 5.2% |
| Inventory | $884.0M | $911.0M | $972.0M |
| Prepaid Expenses | |||
| Receivables | $1.217B | $1.197B | $1.237B |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $3.022B | $3.173B | $3.213B |
| YoY Change | -2.67% | -1.24% | -9.65% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $1.564B | $1.624B | $1.684B |
| YoY Change | -6.35% | -3.56% | -1.64% |
| Goodwill | $5.973B | $5.724B | $9.769B |
| YoY Change | -38.81% | -41.41% | |
| Intangibles | $6.289B | $6.154B | $6.564B |
| YoY Change | -2.84% | -6.25% | |
| Long-Term Investments | $16.00M | ||
| YoY Change | 128.57% | ||
| Other Assets | $306.0M | $223.0M | $272.0M |
| YoY Change | 8.9% | -18.01% | -18.81% |
| Total Long-Term Assets | $14.13B | $13.73B | $18.29B |
| YoY Change | -22.29% | -24.95% | -3.39% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $3.022B | $3.173B | $3.213B |
| Total Long-Term Assets | $14.13B | $13.73B | $18.29B |
| Total Assets | $17.15B | $16.90B | $21.50B |
| YoY Change | -19.43% | -21.41% | -4.38% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $232.0M | $228.0M | $256.0M |
| YoY Change | 14.29% | -10.94% | 31.28% |
| Accrued Expenses | $1.284B | $1.325B | $1.296B |
| YoY Change | -3.24% | 2.24% | -19.2% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $4.000M | $4.000M | |
| YoY Change | 0.0% | -99.56% | |
| Total Short-Term Liabilities | $1.772B | $1.815B | $1.887B |
| YoY Change | -1.94% | -3.82% | -36.14% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $4.252B | $4.252B | $4.259B |
| YoY Change | -0.12% | -0.16% | -17.03% |
| Other Long-Term Liabilities | $2.547B | $2.298B | $1.981B |
| YoY Change | 26.84% | 16.0% | 37.95% |
| Total Long-Term Liabilities | $2.547B | $2.298B | $1.981B |
| YoY Change | 26.84% | 16.0% | -69.84% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $1.772B | $1.815B | $1.887B |
| Total Long-Term Liabilities | $2.547B | $2.298B | $1.981B |
| Total Liabilities | $4.319B | $4.113B | $3.868B |
| YoY Change | 13.21% | 6.33% | -66.21% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$8.449B | -$8.510B | -$4.488B |
| YoY Change | 92.86% | 89.62% | |
| Common Stock | $16.44B | $16.44B | $16.33B |
| YoY Change | 0.49% | 0.67% | |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | $1.092B | $992.0M | $192.0M |
| YoY Change | 121.95% | 416.67% | |
| Treasury Stock Shares | 186.6M shares | 168.7M shares | |
| Shareholders Equity | $6.870B | $6.828B | $11.52B |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $17.15B | $16.90B | $21.50B |
| YoY Change | -19.43% | -21.41% | -4.38% |
Cashflow Statement
| Concept | 2012 Q4 | 2012 Q3 | 2011 Q3 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | $61.00M | -$664.0M | $142.0M |
| YoY Change | -42.99% | -567.61% | -25.26% |
| Depreciation, Depletion And Amortization | $100.0M | $70.00M | $75.00M |
| YoY Change | 4.17% | -6.67% | 4.17% |
| Cash From Operating Activities | $369.0M | $272.0M | $366.0M |
| YoY Change | 5.73% | -25.68% | -390.48% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$66.00M | -$63.00M | -$69.00M |
| YoY Change | -21.43% | -8.7% | -12.66% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | -$207.0M | $10.00M | $10.00M |
| YoY Change | -896.15% | 0.0% | |
| Cash From Investing Activities | -$273.0M | -$53.00M | -$59.00M |
| YoY Change | 370.69% | -10.17% | -25.32% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $192.0M | ||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | -242.0M | -239.0M | -179.0M |
| YoY Change | -19.6% | 33.52% | -1378.57% |
| NET CHANGE | |||
| Cash From Operating Activities | 369.0M | 272.0M | 366.0M |
| Cash From Investing Activities | -273.0M | -53.00M | -59.00M |
| Cash From Financing Activities | -242.0M | -239.0M | -179.0M |
| Net Change In Cash | -146.0M | -20.00M | 128.0M |
| YoY Change | 1360.0% | -115.63% | -167.02% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | $369.0M | $272.0M | $366.0M |
| Capital Expenditures | -$66.00M | -$63.00M | -$69.00M |
| Free Cash Flow | $435.0M | $335.0M | $435.0M |
| YoY Change | 0.46% | -22.99% | -1025.53% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| us-gaap |
Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
|
9000000 | USD | |
| CY2012Q3 | us-gaap |
Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
|
1197000000 | USD |
| CY2011Q4 | us-gaap |
Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
|
1246000000 | USD |
| CY2012Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
228000000 | USD |
| CY2011Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
203000000 | USD |
| CY2012Q3 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
1316000000 | USD |
| CY2011Q4 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
1362000000 | USD |
| CY2011Q4 | us-gaap |
Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
|
1095000000 | USD |
| CY2012Q3 | us-gaap |
Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
|
1162000000 | USD |
| CY2011Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1327000000 | USD |
| CY2012Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1325000000 | USD |
| CY2012Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1569000000 | USD |
| CY2011Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1513000000 | USD |
| CY2011Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
|
-52000000 | USD |
| CY2012Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
|
-34000000 | USD |
| CY2011Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-138000000 | USD |
| CY2012Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-112000000 | USD |
| CY2012Q3 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
16427000000 | USD |
| CY2011Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
16349000000 | USD |
| CY2011Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
81000000 | USD |
| CY2012Q3 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
82000000 | USD |
| CY2012Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
99000000 | USD |
| us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
294000000 | USD | |
| us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
325000000 | USD | |
| CY2011Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
97000000 | USD |
| CY2012Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
62000000 | shares |
| CY2011Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
65000000 | shares |
| CY2011Q4 | us-gaap |
Assets
Assets
|
21290000000 | USD |
| CY2012Q3 | us-gaap |
Assets
Assets
|
16898000000 | USD |
| CY2012Q3 | us-gaap |
Assets Current
AssetsCurrent
|
3173000000 | USD |
| CY2011Q4 | us-gaap |
Assets Current
AssetsCurrent
|
3105000000 | USD |
| CY2012Q3 | us-gaap |
Buildings And Improvements Gross
BuildingsAndImprovementsGross
|
936000000 | USD |
| CY2011Q4 | us-gaap |
Buildings And Improvements Gross
BuildingsAndImprovementsGross
|
923000000 | USD |
| CY2011Q1 | us-gaap |
Business Acquisition Contingent Consideration At Fair Value
BusinessAcquisitionContingentConsiderationAtFairValue
|
287000000 | USD |
| us-gaap |
Business Acquisition Purchase Price Allocation Intangible Assets Description
BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsDescription
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We allocated a portion of the purchase price to specific intangible asset categories as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.140625%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="font-size:9pt;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;text-align:center;">Amount<br clear="none"/>Assigned</font></div><div style="font-size:9pt;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;text-align:center;">(in millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Weighted<br clear="none"/>Average<br clear="none"/>Amortization<br clear="none"/>Period</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(in years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Range of Risk-<br clear="none"/>Adjusted Discount<br clear="none"/>Rates used in<br clear="none"/>Purchase Price<br clear="none"/>Allocation</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortizable intangible assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Technology-related</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Indefinite-lived intangible assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchased research and development</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">90</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div></div></div> | ||
| us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
|
-18000000 | USD | |
| CY2011Q3 | us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
|
-6000000 | USD |
| CY2012Q3 | us-gaap |
Business Combination Contingent Consideration Arrangements Range Of Outcomes Value High
BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
|
1927000000 | USD |
| us-gaap |
Business Combination Goodwill Recognized Segment Allocation
BusinessCombinationGoodwillRecognizedSegmentAllocation
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Goodwill was established due primarily to revenue and cash flow projections associated with future technologies, as well as synergies expected to be gained from the integration of this business into our Cardiac Rhythm Management (CRM) business, and has been allocated to our reportable segments based on the relative expected benefit from the business combinations, as follows (in millions):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.140625%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="85%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">184</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">EMEA</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">97</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inter-Continental</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Japan</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">314</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> | ||
| CY2012Q3 | us-gaap |
Cash
Cash
|
141000000 | USD |
| CY2011Q4 | us-gaap |
Cash
Cash
|
101000000 | USD |
| CY2011Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
267000000 | USD |
| CY2012Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
352000000 | USD |
| CY2010Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
213000000 | USD |
| CY2011Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
276000000 | USD |
| us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
85000000 | USD | |
| us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
63000000 | USD | |
| CY2011Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2012Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2012Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2011Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2012Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
2000000000 | shares |
| CY2011Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
2000000000 | shares |
| CY2011Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
1531006390 | shares |
| CY2012Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
1541569188 | shares |
| CY2011Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
1449055674 | shares |
| CY2012Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
1372871571 | shares |
| CY2011Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
15000000 | USD |
| CY2012Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
15000000 | USD |
| CY2011Q3 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
133000000 | USD |
| us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
331000000 | USD | |
| us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-4103000000 | USD | |
| CY2012Q3 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-689000000 | USD |
| CY2011Q4 | us-gaap |
Construction In Progress Gross
ConstructionInProgressGross
|
230000000 | USD |
| CY2012Q3 | us-gaap |
Construction In Progress Gross
ConstructionInProgressGross
|
203000000 | USD |
| CY2012Q3 | us-gaap |
Cost Method Investments Aggregate Carrying Amount
CostMethodInvestmentsAggregateCarryingAmount
|
13000000 | USD |
| CY2011Q4 | us-gaap |
Cost Method Investments Aggregate Carrying Amount
CostMethodInvestmentsAggregateCarryingAmount
|
16000000 | USD |
| CY2011Q3 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
680000000 | USD |
| CY2012Q3 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
558000000 | USD |
| us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
1999000000 | USD | |
| us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
1767000000 | USD | |
| CY2011Q4 | us-gaap |
Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
|
4261000000 | USD |
| CY2012Q3 | us-gaap |
Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
|
4255000000 | USD |
| CY2011Q4 | us-gaap |
Debt Current
DebtCurrent
|
4000000 | USD |
| CY2012Q3 | us-gaap |
Debt Current
DebtCurrent
|
3000000 | USD |
| CY2012Q3 | us-gaap |
Debt Instrument Fair Value
DebtInstrumentFairValue
|
4861000000 | USD |
| CY2012Q3 | us-gaap |
Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
|
1705000000 | USD |
| CY2011Q4 | us-gaap |
Debt Instrument Fair Value
DebtInstrumentFairValue
|
4649000000 | USD |
| CY2011Q4 | us-gaap |
Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
|
458000000 | USD |
| CY2012Q3 | us-gaap |
Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
|
483000000 | USD |
| CY2011Q4 | us-gaap |
Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
|
1865000000 | USD |
| us-gaap |
Depreciation
Depreciation
|
205000000 | USD | |
| CY2011Q3 | us-gaap |
Depreciation
Depreciation
|
75000000 | USD |
| CY2012Q3 | us-gaap |
Depreciation
Depreciation
|
70000000 | USD |
| us-gaap |
Depreciation
Depreciation
|
215000000 | USD | |
| CY2012Q3 | us-gaap |
Derecognized Assets Securitized Or Assetbacked Financing Arrangement Assets And Any Other Financial Assets Managed Together Principal Amount Outstanding
DerecognizedAssetsSecuritizedOrAssetbackedFinancingArrangementAssetsAndAnyOtherFinancialAssetsManagedTogetherPrincipalAmountOutstanding
|
201000000 | USD |
| CY2011Q4 | us-gaap |
Derecognized Assets Securitized Or Assetbacked Financing Arrangement Assets And Any Other Financial Assets Managed Together Principal Amount Outstanding
DerecognizedAssetsSecuritizedOrAssetbackedFinancingArrangementAssetsAndAnyOtherFinancialAssetsManagedTogetherPrincipalAmountOutstanding
|
390000000 | USD |
| CY2011Q4 | us-gaap |
Derivative Assets
DerivativeAssets
|
87000000 | USD |
| CY2012Q3 | us-gaap |
Derivative Assets
DerivativeAssets
|
51000000 | USD |
| CY2011Q4 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
131000000 | USD |
| CY2012Q3 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
101000000 | USD |
| CY2012Q3 | us-gaap |
Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
|
32000000 | USD |
| us-gaap |
Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
|
91000000 | USD | |
| us-gaap |
Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
|
111000000 | USD | |
| CY2011Q3 | us-gaap |
Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
|
34000000 | USD |
| CY2011Q1 | us-gaap |
Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
|
760000000 | USD |
| CY2012Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.48 | |
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.22 | ||
| CY2011Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.09 | |
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-2.91 | ||
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-2.91 | ||
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.22 | ||
| CY2011Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.09 | |
| CY2012Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.48 | |
| us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
-3000000 | USD | |
| us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
2000000 | USD | |
| us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.384 | ||
| us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.007 | ||
| CY2012Q3 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.001 | |
| CY2011Q3 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.279 | |
| CY2012Q3 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
422000000 | USD |
| CY2011Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
466000000 | USD |
| CY2011Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
-3441000000 | USD |
| CY2012Q3 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
-3688000000 | USD |
| CY2012Q3 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
9240000000 | USD |
| CY2011Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
9170000000 | USD |
| CY2012Q3 | us-gaap |
Foreign Currency Cash Flow Hedge Gain Loss Reclassified To Earnings Net
ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
|
3000000 | USD |
| us-gaap |
Foreign Currency Cash Flow Hedge Gain Loss Reclassified To Earnings Net
ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
|
74000000 | USD | |
| us-gaap |
Foreign Currency Cash Flow Hedge Gain Loss Reclassified To Earnings Net
ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
|
29000000 | USD | |
| CY2011Q3 | us-gaap |
Foreign Currency Cash Flow Hedge Gain Loss Reclassified To Earnings Net
ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
|
28000000 | USD |
| CY2012Q3 | us-gaap |
Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months
ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
|
-31000000 | USD |
| CY2011Q4 | us-gaap |
Foreign Currency Derivative Instruments Not Designated As Hedging Instruments At Fair Value Net
ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet
|
2209000000 | USD |
| CY2012Q3 | us-gaap |
Foreign Currency Derivative Instruments Not Designated As Hedging Instruments At Fair Value Net
ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet
|
1808000000 | USD |
| CY2011Q4 | us-gaap |
Goodwill
Goodwill
|
9761000000 | USD |
| CY2012Q3 | us-gaap |
Goodwill
Goodwill
|
5724000000 | USD |
| us-gaap |
Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
|
314000000 | USD | |
| CY2012Q3 | us-gaap |
Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
|
-9477000000 | USD |
| CY2011Q4 | us-gaap |
Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
|
-5127000000 | USD |
| CY2012Q3 | us-gaap |
Goodwill Impaired Method For Fair Value Determination
GoodwillImpairedMethodForFairValueDetermination
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As previously disclosed in our 2011 Annual Report filed on Form 10-K, our EMEA, U.S. Cardiovascular, U.S. Neuromodulation, and U.S. CRM reporting units had material amounts of goodwill that were at higher risk of potential failure of the first step of the impairment test. </font></div><div style="line-height:120%;padding-top:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In our goodwill impairment tests we used the income approach, specifically the discounted cash flow (DCF) method, to derive the fair value of our EMEA and U.S. CRM reporting units, as described in our accounting policies in our 2011 Annual Report filed on Form 10-K. We updated all aspects of the DCF models associated with the EMEA and U.S. CRM businesses, including the amount and timing of future expected cash flows, terminal value growth rates and the appropriate market-participant risk-adjusted weighted average costs of capital (WACC) to apply.</font></div></div> | |
| us-gaap |
Goodwill Impaired Method For Fair Value Determination
GoodwillImpairedMethodForFairValueDetermination
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As previously disclosed in our 2011 Annual Report filed on Form 10-K, our EMEA, U.S. Cardiovascular, U.S. Neuromodulation, and U.S. CRM reporting units had material amounts of goodwill that were at higher risk of potential failure of the first step of the impairment test. </font></div><div style="line-height:120%;padding-top:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In our goodwill impairment tests we used the income approach, specifically the discounted cash flow (DCF) method, to derive the fair value of our EMEA and U.S. CRM reporting units, as described in our accounting policies in our 2011 Annual Report filed on Form 10-K. We updated all aspects of the DCF models associated with the EMEA and U.S. CRM businesses, including the amount and timing of future expected cash flows, terminal value growth rates and the appropriate market-participant risk-adjusted weighted average costs of capital (WACC) to apply.</font></div></div> | ||
| CY2011Q3 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
USD | |
| us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
4350000000 | USD | |
| us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
697000000 | USD | |
| CY2012Q3 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
748000000 | USD |
| CY2012Q2 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
3602000000 | USD |
| CY2011Q1 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
697000000 | USD |
| us-gaap |
Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
|
-1000000 | USD | |
| us-gaap |
Gross Profit
GrossProfit
|
3775000000 | USD | |
| CY2011Q3 | us-gaap |
Gross Profit
GrossProfit
|
1194000000 | USD |
| us-gaap |
Gross Profit
GrossProfit
|
3661000000 | USD | |
| CY2012Q3 | us-gaap |
Gross Profit
GrossProfit
|
1177000000 | USD |
| CY2012Q3 | us-gaap |
Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
|
13000000 | USD |
| CY2011Q3 | us-gaap |
Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
|
9000000 | USD |
| us-gaap |
Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
|
142000000 | USD | |
| us-gaap |
Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
|
21000000 | USD | |
| CY2012Q2 | us-gaap |
Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
|
129000000 | USD |
| CY2011Q2 | us-gaap |
Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
|
12000000 | USD |
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
542000000 | USD | |
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-4159000000 | USD | |
| CY2012Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-663000000 | USD |
| CY2011Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
111000000 | USD |
| CY2011Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-31000000 | USD |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
208000000 | USD | |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-30000000 | USD | |
| CY2012Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1000000 | USD |
| CY2012Q3 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
6800000 | shares |
| us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
7200000 | shares | |
| CY2011Q4 | us-gaap |
Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
|
15130000000 | USD |
| CY2012Q3 | us-gaap |
Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
|
15443000000 | USD |
| CY2011Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
6473000000 | USD |
| CY2012Q3 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
6154000000 | USD |
| us-gaap |
Interest Expense
InterestExpense
|
210000000 | USD | |
| us-gaap |
Interest Expense
InterestExpense
|
197000000 | USD | |
| CY2012Q3 | us-gaap |
Interest Expense
InterestExpense
|
65000000 | USD |
| CY2011Q3 | us-gaap |
Interest Expense
InterestExpense
|
62000000 | USD |
| CY2012Q3 | us-gaap |
Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net
InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
|
10000000 | USD |
| CY2012Q3 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
617000000 | USD |
| CY2011Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
637000000 | USD |
| CY2011Q4 | us-gaap |
Inventory Net
InventoryNet
|
931000000 | USD |
| CY2012Q3 | us-gaap |
Inventory Net
InventoryNet
|
911000000 | USD |
| CY2011Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
223000000 | USD |
| CY2012Q3 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
215000000 | USD |
| CY2012Q3 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
79000000 | USD |
| CY2011Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
71000000 | USD |
| CY2011Q4 | us-gaap |
Land
Land
|
111000000 | USD |
| CY2012Q3 | us-gaap |
Land
Land
|
111000000 | USD |
| CY2011Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
21290000000 | USD |
| CY2012Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
16898000000 | USD |
| CY2011Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1807000000 | USD |
| CY2012Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1815000000 | USD |
| CY2011Q4 | us-gaap |
Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
|
0 | USD |
| CY2012Q3 | us-gaap |
Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
|
0 | USD |
| CY2011Q4 | us-gaap |
Litigation Reserve Current
LitigationReserveCurrent
|
129000000 | USD |
| CY2012Q3 | us-gaap |
Litigation Reserve Current
LitigationReserveCurrent
|
94000000 | USD |
| CY2012Q3 | us-gaap |
Litigation Reserve Noncurrent
LitigationReserveNoncurrent
|
317000000 | USD |
| CY2011Q4 | us-gaap |
Litigation Reserve Noncurrent
LitigationReserveNoncurrent
|
170000000 | USD |
| CY2012Q3 | us-gaap |
Long Term Debt
LongTermDebt
|
4200000000 | USD |
| CY2011Q4 | us-gaap |
Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
|
4257000000 | USD |
| CY2012Q3 | us-gaap |
Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
|
4252000000 | USD |
| CY2012Q3 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
USD | |
| CY2012Q3 | us-gaap |
Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
|
1750000000 | USD |
| CY2012Q3 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
|
600000000 | USD |
| CY2012Q3 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
|
1250000000 | USD |
| CY2012Q3 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
|
600000000 | USD |
| CY2012Q3 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
|
USD | |
| CY2011Q4 | us-gaap |
Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
|
299000000 | USD |
| CY2012Q3 | us-gaap |
Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
|
411000000 | USD |
| us-gaap |
Loss Contingency Allegations
LossContingencyAllegations
|
5.5 | ||
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-1420000000 | USD | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-502000000 | USD | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-306000000 | USD | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
827000000 | USD | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
659000000 | USD | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
891000000 | USD | |
| us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-192000000 | USD | |
| CY2011Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-63000000 | USD |
| us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-174000000 | USD | |
| CY2012Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-69000000 | USD |
| CY2012Q3 | us-gaap |
Notional Amount Of Foreign Currency Cash Flow Hedge Derivatives
NotionalAmountOfForeignCurrencyCashFlowHedgeDerivatives
|
2293000000 | USD |
| CY2011Q4 | us-gaap |
Notional Amount Of Foreign Currency Cash Flow Hedge Derivatives
NotionalAmountOfForeignCurrencyCashFlowHedgeDerivatives
|
2088000000 | USD |
| CY2011Q4 | us-gaap |
Notional Amount Of Interest Rate Derivatives
NotionalAmountOfInterestRateDerivatives
|
0 | USD |
| CY2012Q3 | us-gaap |
Notional Amount Of Interest Rate Derivatives
NotionalAmountOfInterestRateDerivatives
|
0 | USD |
| us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
4 | reportablesegments | |
| us-gaap |
Operating Expenses
OperatingExpenses
|
7646000000 | USD | |
| us-gaap |
Operating Expenses
OperatingExpenses
|
3041000000 | USD | |
| CY2011Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
1020000000 | USD |
| CY2012Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
1771000000 | USD |
| CY2011Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
174000000 | USD |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
734000000 | USD | |
| CY2012Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-594000000 | USD |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3985000000 | USD | |
| CY2012Q3 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
611000000 | USD |
| CY2011Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
695000000 | USD |
| CY2012Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
223000000 | USD |
| CY2011Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
281000000 | USD |
| us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
9000000 | USD | |
| us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
2000000 | USD | |
| CY2011Q3 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-44000000 | USD |
| CY2012Q3 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
2000000 | USD |
| CY2011Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-9000000 | USD |
| us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
26000000 | USD | |
| us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-3000000 | USD | |
| CY2012Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-25000000 | USD |
| us-gaap |
Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
|
-5000000 | USD | |
| CY2011Q3 | us-gaap |
Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
|
35000000 | USD |
| us-gaap |
Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
|
17000000 | USD | |
| CY2012Q3 | us-gaap |
Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
|
-27000000 | USD |
| CY2011Q3 | us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
6000000 | USD |
| CY2012Q3 | us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
-20000000 | USD |
| us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
-9000000 | USD | |
| us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
18000000 | USD | |
| CY2011Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
273000000 | USD |
| CY2012Q3 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
259000000 | USD |
| CY2011Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
2008000000 | USD |
| CY2012Q3 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
2298000000 | USD |
| us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
18000000 | USD | |
| CY2012Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-4000000 | USD |
| CY2011Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-1000000 | USD |
| us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
23000000 | USD | |
| us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
192000000 | USD | |
| us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
500000000 | USD | |
| CY2012Q3 | us-gaap |
Payments For Restructuring
PaymentsForRestructuring
|
24000000 | USD |
| us-gaap |
Payments For Restructuring
PaymentsForRestructuring
|
89000000 | USD | |
| us-gaap |
Payments For Restructuring
PaymentsForRestructuring
|
315000000 | USD | |
| us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
134000000 | USD | |
| us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
370000000 | USD | |
| us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
10000000 | USD | |
| us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
18000000 | USD | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
221000000 | USD | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
164000000 | USD | |
| CY2011Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
| CY2012Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
| CY2011Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
| CY2012Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
| CY2011Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2012Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2012Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2011Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2012Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
USD | |
| CY2011Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
USD | |
| CY2011Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
203000000 | USD |
| CY2012Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
230000000 | USD |
| us-gaap |
Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
|
1426000000 | USD | |
| us-gaap |
Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
|
10000000 | USD | |
| CY2011Q1 | us-gaap |
Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
|
1450000000 | USD |
| us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
20000000 | USD | |
| us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
22000000 | USD | |
| us-gaap |
Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
|
425000000 | USD | |
| us-gaap |
Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
|
251000000 | USD | |
| CY2011Q3 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
35000000 | USD |
| CY2011Q4 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
30000000 | USD |
| CY2010Q4 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
43000000 | USD |
| CY2012Q3 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
27000000 | USD |
| us-gaap |
Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
|
12000000 | USD | |
| us-gaap |
Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
|
6000000 | USD | |
| us-gaap |
Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
|
4000000 | USD | |
| CY2012Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-664000000 | USD |
| us-gaap |
Profit Loss
ProfitLoss
|
334000000 | USD | |
| CY2011Q3 | us-gaap |
Profit Loss
ProfitLoss
|
142000000 | USD |
| us-gaap |
Profit Loss
ProfitLoss
|
-4129000000 | USD | |
| CY2011Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
3183000000 | USD |
| CY2012Q3 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
3193000000 | USD |
| CY2012Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1624000000 | USD |
| CY2011Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1670000000 | USD |
| us-gaap |
Receivable With Imputed Interest Effective Yield Interest Rate
ReceivableWithImputedInterestEffectiveYieldInterestRate
|
0.025 | ||
| CY2011 | us-gaap |
Receivable With Imputed Interest Effective Yield Interest Rate
ReceivableWithImputedInterestEffectiveYieldInterestRate
|
0.033 | |
| us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
9000000 | USD | |
| us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
1250000000 | USD | |
| us-gaap |
Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
|
425000000 | USD | |
| us-gaap |
Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
|
260000000 | USD | |
| us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
665000000 | USD | |
| CY2011Q3 | us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
229000000 | USD |
| us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
648000000 | USD | |
| CY2012Q3 | us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
220000000 | USD |
| us-gaap |
Restructuring And Related Cost Cost Incurred To Date
RestructuringAndRelatedCostCostIncurredToDate
|
424000000 | USD | |
| CY2012Q3 | us-gaap |
Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
|
58000000 | USD |
| CY2011Q3 | us-gaap |
Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
|
29000000 | USD |
| us-gaap |
Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
|
108000000 | USD | |
| us-gaap |
Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
|
109000000 | USD | |
| CY2011Q3 | us-gaap |
Restructuring Charges
RestructuringCharges
|
22000000 | USD |
| us-gaap |
Restructuring Charges
RestructuringCharges
|
77000000 | USD | |
| us-gaap |
Restructuring Charges
RestructuringCharges
|
93000000 | USD | |
| CY2012Q3 | us-gaap |
Restructuring Charges
RestructuringCharges
|
54000000 | USD |
| us-gaap |
Restructuring Charges
RestructuringCharges
|
313000000 | USD | |
| CY2011 | us-gaap |
Restructuring Charges
RestructuringCharges
|
92000000 | USD |
| CY2010 | us-gaap |
Restructuring Charges
RestructuringCharges
|
98000000 | USD |
| CY2012Q3 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
79000000 | USD |
| CY2011Q4 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
60000000 | USD |
| CY2009Q4 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
22000000 | USD |
| CY2010Q4 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
55000000 | USD |
| us-gaap |
Restructuring Reserve Period Increase Decrease
RestructuringReservePeriodIncreaseDecrease
|
101000000 | USD | |
| CY2010 | us-gaap |
Restructuring Reserve Settled With Cash
RestructuringReserveSettledWithCash
|
65000000 | USD |
| us-gaap |
Restructuring Reserve Settled With Cash
RestructuringReserveSettledWithCash
|
82000000 | USD | |
| CY2011 | us-gaap |
Restructuring Reserve Settled With Cash
RestructuringReserveSettledWithCash
|
87000000 | USD |
| CY2011Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-4381000000 | USD |
| CY2012Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-8510000000 | USD |
| us-gaap |
Royalty Expense
RoyaltyExpense
|
125000000 | USD | |
| us-gaap |
Royalty Expense
RoyaltyExpense
|
140000000 | USD | |
| CY2012Q3 | us-gaap |
Royalty Expense
RoyaltyExpense
|
29000000 | USD |
| CY2011Q3 | us-gaap |
Royalty Expense
RoyaltyExpense
|
36000000 | USD |
| CY2011Q3 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
1874000000 | USD |
| CY2012Q3 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
1735000000 | USD |
| us-gaap |
Sales Revenue Net
SalesRevenueNet
|
5774000000 | USD | |
| us-gaap |
Sales Revenue Net
SalesRevenueNet
|
5428000000 | USD | |
| us-gaap |
Segment Reporting Information Revenue
SegmentReportingInformationRevenue
|
5559000000 | USD | |
| us-gaap |
Segment Reporting Information Revenue
SegmentReportingInformationRevenue
|
5338000000 | USD | |
| CY2012Q3 | us-gaap |
Segment Reporting Information Revenue
SegmentReportingInformationRevenue
|
1706000000 | USD |
| CY2011Q3 | us-gaap |
Segment Reporting Information Revenue
SegmentReportingInformationRevenue
|
1796000000 | USD |
| CY2012Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
589000000 | USD |
| us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
1866000000 | USD | |
| CY2011Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
629000000 | USD |
| us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
1895000000 | USD | |
| CY2012Q3 | us-gaap |
Senior Notes
SeniorNotes
|
4200000000 | USD |
| CY2011Q4 | us-gaap |
Senior Notes
SeniorNotes
|
4200000000 | USD |
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
96000000 | USD | |
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
85000000 | USD | |
| us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
10000000 | shares | |
| CY2011Q3 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
2000000 | shares |
| us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
11000000 | shares | |
| CY2012Q3 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
3000000 | shares |
| CY2012Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
6828000000 | USD |
| CY2011Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
11353000000 | USD |
| CY2012Q3 | us-gaap |
Time Deposits At Carrying Value
TimeDepositsAtCarryingValue
|
147000000 | USD |
| CY2011Q4 | us-gaap |
Time Deposits At Carrying Value
TimeDepositsAtCarryingValue
|
88000000 | USD |
| CY2011Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
81950716 | shares |
| CY2012Q3 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
168697617 | shares |
| us-gaap |
Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
|
87000000 | shares | |
| CY2012Q3 | us-gaap |
Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
|
46000000 | shares |
| CY2011Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
492000000 | USD |
| CY2012Q3 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
992000000 | USD |
| CY2011Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
952000000 | USD |
| CY2012Q3 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
990000000 | USD |
| CY2012Q3 | us-gaap |
Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
|
885000000 | USD |
| CY2011Q4 | us-gaap |
Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
|
847000000 | USD |
| CY2011Q3 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
75000000 | USD |
| CY2012Q3 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
82000000 | USD |
| CY2011Q2 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
67000000 | USD |
| CY2011Q4 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
81000000 | USD |
| CY2010Q4 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
83000000 | USD |
| CY2012Q2 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
83000000 | USD |
| CY2012Q3 | us-gaap |
Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
|
1000000 | USD |
| CY2011Q3 | us-gaap |
Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
|
12000000 | USD |
| us-gaap |
Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
|
7000000 | USD | |
| us-gaap |
Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
|
1000000 | USD | |
| us-gaap |
Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
|
6000000 | USD | |
| us-gaap |
Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
|
9000000 | USD | |
| CY2012Q3 | us-gaap |
Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
|
2000000 | USD |
| CY2011Q3 | us-gaap |
Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
|
4000000 | USD |
| CY2011Q3 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
9600000 | shares |
| us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
8900000 | shares | |
| CY2012Q3 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
shares | |
| CY2011Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
1524000000 | shares |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
1420300000 | shares | |
| us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
shares | ||
| CY2012Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
1392500000 | shares |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
1532000000 | shares | |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1523100000 | shares | |
| CY2012Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1392500000 | shares |
| CY2011Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1514400000 | shares |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1420300000 | shares | |
| CY2012Q3 | bsx |
Accrued Contingent Consideration
AccruedContingentConsideration
|
604000000 | USD |
| CY2011Q4 | bsx |
Accrued Contingent Consideration
AccruedContingentConsideration
|
358000000 | USD |
| CY2012Q3 | bsx |
Accrued Contingent Consideration Current
AccruedContingentConsiderationCurrent
|
198000000 | USD |
| CY2011Q4 | bsx |
Accrued Contingent Consideration Current
AccruedContingentConsiderationCurrent
|
37000000 | USD |
| CY2011Q4 | bsx |
Accrued Contingent Consideration Non Current
AccruedContingentConsiderationNonCurrent
|
321000000 | USD |
| CY2012Q3 | bsx |
Accrued Contingent Consideration Non Current
AccruedContingentConsiderationNonCurrent
|
406000000 | USD |
| CY2011Q4 | bsx |
Accrued Interest And Penalties Gross
AccruedInterestAndPenaltiesGross
|
313000000 | USD |
| CY2012Q3 | bsx |
Accrued Interest And Penalties Gross
AccruedInterestAndPenaltiesGross
|
351000000 | USD |
| CY2011 | bsx |
Agreement To Settle Tpp Matters
AgreementToSettleTppMatters
|
3000000 | USD |
| CY2012Q3 | bsx |
Allowance For Sales Returns Current
AllowanceForSalesReturnsCurrent
|
37000000 | USD |
| CY2011Q4 | bsx |
Allowance For Sales Returns Current
AllowanceForSalesReturnsCurrent
|
35000000 | USD |
| CY2011Q1 | bsx |
Amount Placed In Escrow Included In Proceeds From Divestiture Of Business
AmountPlacedInEscrowIncludedInProceedsFromDivestitureOfBusiness
|
24000000 | USD |
| bsx |
Benefit Related To Change In Fair Value Of Contingent Liability
BenefitRelatedToChangeInFairValueOfContingentLiability
|
9000000 | USD | |
| CY2012Q3 | bsx |
Benefit Related To Change In Fair Value Of Contingent Liability
BenefitRelatedToChangeInFairValueOfContingentLiability
|
20000000 | USD |
| CY2011Q1 | bsx |
Business Combination Equity Ownership Before Transaction
BusinessCombinationEquityOwnershipBeforeTransaction
|
11000000 | |
| CY2012Q2 | bsx |
Cash Receipts Government Funded Settlement Spain Receivables
CashReceiptsGovernmentFundedSettlementSpainReceivables
|
60000000 | USD |
| CY2012Q3 | bsx |
Cash Receipts Government Funded Settlement Spain Receivables
CashReceiptsGovernmentFundedSettlementSpainReceivables
|
28000000 | USD |
| CY2012Q4 | bsx |
Contingent Consideration Q412 Acqs
ContingentConsiderationQ412Acqs
|
265000000 | USD |
| bsx |
Contingent Consideration Recognized In Period
ContingentConsiderationRecognizedInPeriod
|
259000000 | USD | |
| bsx |
Contingent Payment Related To Business Combination
ContingentPaymentRelatedToBusinessCombination
|
4000000 | USD | |
| CY2012Q3 | bsx |
Contingent Payment Related To Business Combination
ContingentPaymentRelatedToBusinessCombination
|
0 | USD |
| bsx |
Contingent Payment Related To Business Combination
ContingentPaymentRelatedToBusinessCombination
|
0 | USD | |
| CY2012Q3 | bsx |
Contingent Receivable For Divestiture Of Business
ContingentReceivableForDivestitureOfBusiness
|
40000000 | USD |
| CY2012Q3 | bsx |
Discount Rate Used For Measurement Of Fair Value Of Asthmax Intelect Iprd Asset Maximum
DiscountRateUsedForMeasurementOfFairValueOfAsthmaxIntelectIprdAssetMaximum
|
0.25 | |
| CY2012Q3 | bsx |
Discount Rate Used For Measurement Of Fair Value Of Asthmax Intelect Iprd Asset Minimum
DiscountRateUsedForMeasurementOfFairValueOfAsthmaxIntelectIprdAssetMinimum
|
0.20 | |
| CY2012Q2 | bsx |
Discount Rate Used For Measurement Of Fair Value Of Sadra Iprd Asset
DiscountRateUsedForMeasurementOfFairValueOfSadraIprdAsset
|
0.20 | |
| bsx |
Effective Tax Rate
EffectiveTaxRate
|
0.152 | ||
| bsx |
Effective Tax Rate
EffectiveTaxRate
|
0.166 | ||
| CY2011Q3 | bsx |
Effective Tax Rate
EffectiveTaxRate
|
0.201 | |
| CY2012Q3 | bsx |
Effective Tax Rate
EffectiveTaxRate
|
0.161 | |
| CY2011Q4 | bsx |
Equipment Furniture And Fixtures Gross
EquipmentFurnitureAndFixturesGross
|
1919000000 | USD |
| CY2012Q3 | bsx |
Equipment Furniture And Fixtures Gross
EquipmentFurnitureAndFixturesGross
|
1943000000 | USD |
| CY2011Q1 | bsx |
Gain On Divestiture Of Business Net Of Tax
GainOnDivestitureOfBusinessNetOfTax
|
530000000 | USD |
| bsx |
Gain On Divestitures
GainOnDivestitures
|
768000000 | USD | |
| CY2012Q3 | bsx |
Gain On Divestitures
GainOnDivestitures
|
11000000 | USD |
| CY2011Q3 | bsx |
Gain On Divestitures
GainOnDivestitures
|
8000000 | USD |
| bsx |
Gain On Divestitures
GainOnDivestitures
|
11000000 | USD | |
| CY2011Q3 | bsx |
Gain Related To Ineffective Portion Of Hedging Relationships
GainRelatedToIneffectivePortionOfHedgingRelationships
|
0 | USD |
| bsx |
Gain Related To Ineffective Portion Of Hedging Relationships
GainRelatedToIneffectivePortionOfHedgingRelationships
|
0 | USD | |
| bsx |
Gain Related To Ineffective Portion Of Hedging Relationships
GainRelatedToIneffectivePortionOfHedgingRelationships
|
0 | USD | |
| CY2012Q3 | bsx |
Gain Related To Ineffective Portion Of Hedging Relationships
GainRelatedToIneffectivePortionOfHedgingRelationships
|
0 | USD |
| CY2012Q3 | bsx |
Goodwill And Intangible Asset Impairment Losses In Period
GoodwillAndIntangibleAssetImpairmentLossesInPeriod
|
761000000 | USD |
| bsx |
Goodwill And Intangible Asset Impairment Losses In Period
GoodwillAndIntangibleAssetImpairmentLossesInPeriod
|
4492000000 | USD | |
| CY2012Q2 | bsx |
Goodwill Impairment Loss Net Of Tax
GoodwillImpairmentLossNetOfTax
|
3579000000 | USD |
| bsx |
Impact Of Certain Receipts Charges
ImpactOfCertainReceiptsCharges
|
-0.218 | ||
| bsx |
Impact Of Certain Receipts Charges
ImpactOfCertainReceiptsCharges
|
0.145 | ||
| CY2011Q3 | bsx |
Impact Of Certain Receipts Charges
ImpactOfCertainReceiptsCharges
|
0.480 | |
| CY2012Q3 | bsx |
Impact Of Certain Receipts Charges
ImpactOfCertainReceiptsCharges
|
0.162 | |
| bsx |
Impact Of Foreign Currency Fluctuations On Net Sales
ImpactOfForeignCurrencyFluctuationsOnNetSales
|
104000000 | USD | |
| bsx |
Impact Of Foreign Currency Fluctuations On Net Sales
ImpactOfForeignCurrencyFluctuationsOnNetSales
|
-1000000 | USD | |
| CY2011Q3 | bsx |
Impact Of Foreign Currency Fluctuations On Net Sales
ImpactOfForeignCurrencyFluctuationsOnNetSales
|
44000000 | USD |
| CY2012Q3 | bsx |
Impact Of Foreign Currency Fluctuations On Net Sales
ImpactOfForeignCurrencyFluctuationsOnNetSales
|
-3000000 | USD |
| CY2012Q3 | bsx |
In Process Research And Development Associated With Asthmax Intelect
InProcessResearchAndDevelopmentAssociatedWithAsthmaxIntelect
|
26000000 | USD |
| CY2012Q2 | bsx |
In Process Research And Development Associated With Sadra
InProcessResearchAndDevelopmentAssociatedWithSadra
|
184000000 | USD |
| CY2012Q3 | bsx |
Incremental Tax Liability Asserted By Irs
IncrementalTaxLiabilityAssertedByIrs
|
1162000000 | USD |
| CY2011Q4 | bsx |
Indefinite Lived Intangible Assets Accumulated Write Offs
IndefiniteLivedIntangibleAssetsAccumulatedWriteOffs
|
-5127000000 | USD |
| CY2012Q3 | bsx |
Indefinite Lived Intangible Assets Accumulated Write Offs
IndefiniteLivedIntangibleAssetsAccumulatedWriteOffs
|
-9477000000 | USD |
| CY2012Q2 | bsx |
Initial Cash Payment For Cameron Acquisition
InitialCashPaymentForCameronAcquisition
|
150000000 | USD |
| CY2012Q4 | bsx |
Initial Cash Payments For Bridgepoint And Rhythmia Acqs
InitialCashPaymentsForBridgepointAndRhythmiaAcqs
|
100000000 | USD |
| CY2012Q3 | bsx |
Inprocessresearchanddevelopmentreclassified
Inprocessresearchanddevelopmentreclassified
|
47000000 | USD |
| CY2012Q2 | bsx |
Intangible Asset Impairment Charge Net Of Tax
IntangibleAssetImpairmentChargeNetOfTax
|
110000000 | USD |
| CY2012Q3 | bsx |
Intangible Asset Impairment Charge Net Of Tax
IntangibleAssetImpairmentChargeNetOfTax
|
10000000 | USD |
| CY2011Q3 | bsx |
Interest Expense Related To Income Taxes
InterestExpenseRelatedToIncomeTaxes
|
4000000 | USD |
| CY2012Q3 | bsx |
Interest Expense Related To Income Taxes
InterestExpenseRelatedToIncomeTaxes
|
15000000 | USD |
| bsx |
Interest Expense Related To Income Taxes
InterestExpenseRelatedToIncomeTaxes
|
26000000 | USD | |
| bsx |
Interest Expense Related To Income Taxes
InterestExpenseRelatedToIncomeTaxes
|
12000000 | USD | |
| CY2012Q2 | bsx |
Litigation Related Charges
LitigationRelatedCharges
|
85000000 | USD |
| bsx |
Litigation Related Charges Credits
LitigationRelatedChargesCredits
|
119000000 | USD | |
| bsx |
Litigation Related Charges Credits
LitigationRelatedChargesCredits
|
USD | ||
| CY2011Q3 | bsx |
Litigation Related Charges Credits
LitigationRelatedChargesCredits
|
USD | |
| CY2012Q3 | bsx |
Litigation Related Charges Credits
LitigationRelatedChargesCredits
|
50000000 | USD |
| CY2012Q2 | bsx |
Litigation Related Charges Credits
LitigationRelatedChargesCredits
|
69000000 | USD |
| CY2012Q2 | bsx |
Litigationrelatedcredit
Litigationrelatedcredit
|
16000000 | USD |
| CY2012Q3 | bsx |
Maximum Amount Of Proceeds From Sale Of Finance Receivables
MaximumAmountOfProceedsFromSaleOfFinanceReceivables
|
298000000 | USD |
| CY2012Q3 | bsx |
Maximum Amount Of Proceeds From Sale Of Finance Receivables
MaximumAmountOfProceedsFromSaleOfFinanceReceivables
|
230000000 | EUR |
| CY2012Q3 | bsx |
Maximum Potential Payment Due Upon Achievement Of Certain Milestones Per Cameron Agreement
MaximumPotentialPaymentDueUponAchievementOfCertainMilestonesPerCameronAgreement
|
1050000000 | USD |
| CY2007Q4 | bsx |
Maximum Potential Payment Related To Mdl Settlement
MaximumPotentialPaymentRelatedToMdlSettlement
|
240000000 | USD |
| CY2011Q1 | bsx |
Note Receivable
NoteReceivable
|
6000000 | USD |
| CY2012Q3 | bsx |
Number Of Reporting Units With Material Goodwill At Higher Risk Of Failure Of Step One Of Impairment Test
NumberOfReportingUnitsWithMaterialGoodwillAtHigherRiskOfFailureOfStepOneOfImpairmentTest
|
3 | reportingunits |
| bsx |
Operating Income Allocated To Reportable Segments
OperatingIncomeAllocatedToReportableSegments
|
1440000000 | USD | |
| bsx |
Payment Made In Multi District Litigation Settlement
PaymentMadeInMultiDistrictLitigationSettlement
|
234000000 | USD | |
| bsx |
Payment Of Contingent Consideration
PaymentOfContingentConsideration
|
USD | ||
| bsx |
Payment Of Contingent Consideration
PaymentOfContingentConsideration
|
4000000 | USD | |
| bsx |
Payments For Repurchase Of Common Stock Rounded
PaymentsForRepurchaseOfCommonStockRounded
|
500000000 | USD | |
| CY2012Q3 | bsx |
Payments For Repurchase Of Common Stock Rounded
PaymentsForRepurchaseOfCommonStockRounded
|
250000000 | USD |
| CY2012Q3 | bsx |
Potential Payment Due Upon Fda Approval Of S Icd System
PotentialPaymentDueUponFdaApprovalOfSIcdSystem
|
150000000 | USD |
| CY2012Q3 | bsx |
Operating Income Allocated To Reportable Segments
OperatingIncomeAllocatedToReportableSegments
|
458000000 | USD |
| CY2011Q3 | bsx |
Operating Income Allocated To Reportable Segments
OperatingIncomeAllocatedToReportableSegments
|
463000000 | USD |
| bsx |
Operating Income Allocated To Reportable Segments
OperatingIncomeAllocatedToReportableSegments
|
1552000000 | USD | |
| CY2011Q4 | bsx |
Other Long Term Liabilities
OtherLongTermLiabilities
|
422000000 | USD |
| CY2012Q3 | bsx |
Other Long Term Liabilities
OtherLongTermLiabilities
|
413000000 | USD |
| CY2013 | bsx |
Potential Reduction In Unrecognized Tax Benefits Over Next Twelve Months As Result Of Concluding Certain Matters
PotentialReductionInUnrecognizedTaxBenefitsOverNextTwelveMonthsAsResultOfConcludingCertainMatters
|
34000000 | USD |
| CY2011Q1 | bsx |
Proceeds From Divestiture Of Business Excluding Amounts Placed In Escrow
ProceedsFromDivestitureOfBusinessExcludingAmountsPlacedInEscrow
|
1426000000 | USD |
| bsx |
Proceeds From Sales Of Equity Securities And Collections Of Notes Receivable
ProceedsFromSalesOfEquitySecuritiesAndCollectionsOfNotesReceivable
|
2000000 | USD | |
| bsx |
Proceeds From Sales Of Equity Securities And Collections Of Notes Receivable
ProceedsFromSalesOfEquitySecuritiesAndCollectionsOfNotesReceivable
|
USD | ||
| CY2012Q3 | bsx |
Product Liability Cases Or Claims Related To Mesh Product
ProductLiabilityCasesOrClaimsRelatedToMeshProduct
|
2500 | claims |
| CY2011Q1 | bsx |
Purchase Price For Divestiture Of Business
PurchasePriceForDivestitureOfBusiness
|
1500000000 | USD |
| bsx |
Reduction Of Interest Expense Related To Amortization Of Previously Terminated Interest Rate Contracts
ReductionOfInterestExpenseRelatedToAmortizationOfPreviouslyTerminatedInterestRateContracts
|
8000000 | USD | |
| CY2012Q3 | bsx |
Reduction Of Interest Expense Related To Amortization Of Previously Terminated Interest Rate Contracts
ReductionOfInterestExpenseRelatedToAmortizationOfPreviouslyTerminatedInterestRateContracts
|
3000000 | USD |
| bsx |
Restructuring Charges Incurred To Date
RestructuringChargesIncurredToDate
|
313000000 | USD | |
| bsx |
Restructuring Related Costs Incurred To Date
RestructuringRelatedCostsIncurredToDate
|
111000000 | USD | |
| CY2011Q3 | bsx |
Restructuring Related Expenses
RestructuringRelatedExpenses
|
7000000 | USD |
| CY2012Q3 | bsx |
Restructuring Related Expenses
RestructuringRelatedExpenses
|
4000000 | USD |
| bsx |
Restructuring Related Expenses
RestructuringRelatedExpenses
|
111000000 | USD | |
| bsx |
Restructuring Related Expenses
RestructuringRelatedExpenses
|
32000000 | USD | |
| bsx |
Restructuring Related Expenses
RestructuringRelatedExpenses
|
15000000 | USD | |
| bsx |
Reversal Of Bad Debt Expense
ReversalOfBadDebtExpense
|
20000000 | USD | |
| bsx |
Segment Reporting Sales From Divested Businesses
SegmentReportingSalesFromDivestedBusinesses
|
111000000 | USD | |
| bsx |
Segment Reporting Sales From Divested Businesses
SegmentReportingSalesFromDivestedBusinesses
|
91000000 | USD | |
| CY2011Q3 | bsx |
Segment Reporting Sales From Divested Businesses
SegmentReportingSalesFromDivestedBusinesses
|
34000000 | USD |
| CY2012Q3 | bsx |
Segment Reporting Sales From Divested Businesses
SegmentReportingSalesFromDivestedBusinesses
|
32000000 | USD |
| bsx |
Transaction Costs Associated With2011 And2012 Acquisitions
TransactionCostsAssociatedWith2011And2012Acquisitions
|
0 | USD | |
| CY2012Q3 | bsx |
Transaction Costs Associated With2011 And2012 Acquisitions
TransactionCostsAssociatedWith2011And2012Acquisitions
|
0 | USD |
| CY2011Q3 | bsx |
Transaction Costs Associated With2011 And2012 Acquisitions
TransactionCostsAssociatedWith2011And2012Acquisitions
|
0 | USD |
| bsx |
Transaction Costs Associated With2011 And2012 Acquisitions
TransactionCostsAssociatedWith2011And2012Acquisitions
|
0 | USD | |
| CY2012Q3 | bsx |
Unamortized Gains On Senior Notes
UnamortizedGainsOnSeniorNotes
|
66000000 | USD |
| CY2011Q4 | bsx |
Unamortized Gains On Senior Notes
UnamortizedGainsOnSeniorNotes
|
73000000 | USD |
| CY2012Q3 | bsx |
Unamortized Losses On Senior Notes
UnamortizedLossesOnSeniorNotes
|
3000000 | USD |
| CY2011Q4 | bsx |
Unamortized Losses On Senior Notes
UnamortizedLossesOnSeniorNotes
|
4000000 | USD |
| CY2012Q3 | bsx |
Unrealized Gain On Interest Rate Cash Flow Hedges Pretax Aoci
UnrealizedGainOnInterestRateCashFlowHedgesPretaxAoci
|
6000000 | USD |
| CY2011Q4 | bsx |
Unrealized Gain On Interest Rate Cash Flow Hedges Pretax Aoci
UnrealizedGainOnInterestRateCashFlowHedgesPretaxAoci
|
7000000 | USD |
| dei |
Amendment Flag
AmendmentFlag
|
false | ||
| dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
| dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
| dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2012 | ||
| dei |
Document Period End Date
DocumentPeriodEndDate
|
2012-09-30 | ||
| dei |
Document Type
DocumentType
|
10-Q | ||
| dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000885725 | ||
| CY2012Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
1372983740 | shares |
| dei |
Entity Filer Category
EntityFilerCategory
|
Large Accelerated Filer | ||
| dei |
Entity Registrant Name
EntityRegistrantName
|
BOSTON SCIENTIFIC CORPORATION |
